We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current KZR market cap is 517.3M. The company's latest EPS is USD -1.3962 and P/E is -5.08.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 7M | 0 | 0 | 0 |
| Operating Income | -26.78M | -25.53M | -34.59M | -23.71M | -23.38M |
| Net Income | -24.31M | -23.1M | -32.26M | -21.66M | -21.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 7M |
| Operating Income | -37.34M | -42.95M | -54.66M | -71.16M | -111.42M |
| Net Income | -35.09M | -41.74M | -54.63M | -68.24M | -101.87M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 263.38M | 249.33M | 221.24M | 199.13M | 179.92M |
| Total Liabilities | 31.1M | 33.33M | 33.67M | 30.01M | 29.24M |
| Total Equity | 232.28M | 215.99M | 187.57M | 169.12M | 150.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 89.51M | 151.84M | 217.93M | 299.57M | 221.24M |
| Total Liabilities | 11.47M | 10.86M | 21.06M | 29.7M | 33.67M |
| Total Equity | 78.05M | 140.98M | 196.88M | 269.87M | 187.57M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.46M | -62.67M | -81.65M | -22.86M | -39.89M |
| Investing | 29.59M | 48.17M | 76.05M | 20.41M | 32.62M |
| Financing | 536k | 579k | 638k | N/A | 56k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.88M | -36.95M | -42.44M | -58.85M | -81.65M |
| Investing | 20.42M | -56.5M | -28.44M | -91.39M | 76.05M |
| Financing | 272k | 99.64M | 112.59M | 127.86M | 638k |
| Market Cap | 517.3M |
| Price to Earnings Ratio | -5.08 |
| Price to Sales Ratio | 73.93 |
| Price to Cash Ratio | 14.57 |
| Price to Book Ratio | 2.76 |
| Dividend Yield | - |
| Shares Outstanding | 72.96M |
| Average Volume (1 week) | 525.74k |
| Average Volume (1 Month) | 910.84k |
| 52 Week Change | -15.26% |
| 52 Week High | 11.35 |
| 52 Week Low | 5.016 |
| Spread (Intraday) | 0.22 (3.04%) |
| Company Name | Kezar Life Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://kezarlifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
